Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $589
Morgan Stanley analyst Erin Wright maintains $IDEXX Laboratories Inc(IDXX.US)$ with a buy rating, and adjusts the target price from $596 to $589.According to TipRanks data, the analyst has a success
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $589 From $596, Maintains Overweight Rating
IDEXX Laboratories (IDXX) has an average outperform rating and a price target range of $400 to $641, according to analysts polled by Capital IQ.Price: 484.01, Change: +1.31, Percent Change: +0.27
Shareholders Are Optimistic That IDEXX Laboratories (NASDAQ:IDXX) Will Multiply In Value
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $510
Stifel analyst Jonathan Block maintains $IDEXX Laboratories Inc(IDXX.US)$ with a hold rating, and maintains the target price at $510.According to TipRanks data, the analyst has a success rate of 48.5%
P/E Ratio Insights for IDEXX Laboratories
In the current market session, IDEXX Laboratories Inc. (NASDAQ:IDXX) price is at $487.60, after a 0.87% increase. However, over the past month, the stock fell by 3.66%, and in the past year, by 9.18%.
TMO or IDXX: Which Is the Better Value Stock Right Now?
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only
Looking Into IDEXX Laboratories's Recent Short Interest
IDEXX Laboratories's (NYSE:IDXX) short percent of float has risen 17.34% since its last report. The company recently reported that it has 2.05 million shares sold short, which is 3.18% of all
Should You Invest in IDEXX Laboratories (IDXX)?
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 11.08% on an annualized basis producing an average annual return of 22.02%. Currently, IDEXX Laboratories has a m
Jiangsu Leili Motor (300660.SZ): Downstream customers include multiple global medical instrument leading enterprises, such as Shenzhen Mindray Bio-Medical Electronics, IDEXX Laboratories Inc, Siemens, etc.
Jiangsu Leili Motor (300660.SZ) stated on its investor interaction platform on July 3 that the company has accumulated various types of products under categories such as linear actuators and voice coil motors in the medical field. Downstream customers include multiple global medical equipment industry leaders, such as Shenzhen Mindray Bio-medical Electronics, Idexx Laboratories Inc, and Siemens. The company has established a strategic partnership with Shenzhen Mindray Bio-medical Electronics to jointly promote the localization of core components of medical instruments. The company has advantages in excellent product performance, complete series, high global market recognition, outstanding product customization and technical research and development capabilities in the field.
IDEXX Laboratories to Release 2024 Second Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, August 6, 2024, before the market opens. The Company will
IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Laboratories Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/24/2024 2.88% Stifel $520 → $510 Maintains Hold 05/14/2024 20.23% Morgan Stanley $620 → $596 Maintains
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $510
Stifel analyst Jonathan Block maintains $IDEXX Laboratories Inc(IDXX.US)$ with a hold rating, and adjusts the target price from $520 to $510.According to TipRanks data, the analyst has a success rate
Express News | IDEXX Laboratories Inc : Stifel Cuts Target Price to $510 From $520
Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $520
IDEXX Laboratories (IDXX) has an average rating of outperform and price targets ranging from $400 to $641, according to analysts polled by Capital IQ. Price: 493.65, Change: -2.08, Percent Change: -0.
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Makes An Interesting Case
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,600 Today
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 11.41% on an annualized basis producing an average annual return of 22.31%. Currently, IDEXX Laboratories has a m